We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

KWR:NYSEQuaker Houghton analysis

Data as of Oct 11, 2026 - not real-time

Latest price
$155.95
Risk: medium
7/10Medium risk

Summary

The moving-average structure behind Quaker Chemical Corporation is neutral at $155.95, with no clear ordering between short and long averages. Across the trailing 30 sessions it lost 5.1%. RSI sits at 43.1, which reads as neutral, and MACD momentum is bearish. Recent trading has carved out support near $151.96 and resistance around $163.79.
On valuation the read is fair — an earnings multiple of 27.8, absent a reliable peer benchmark. The average analyst target implies 23.5% above today's level. Revenue is growing at 10.2% on a 4.9% profit margin. The 1.34% dividend yield looks covered by current payout levels.
Risk scores 7 out of 10, which is elevated for this asset class. With 30-day volatility of 22.1%, a beta of 1.30 and a maximum drawdown of 36.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
This one splits by horizon — hold in the near term, buy further out, at 5/10 long-term conviction.

Top market events

  • Quaker Chemical Corporation recently reported that for the second quarter of 2026, sales were US$532.
  • Record EBITDA and 28% EPS growth despite margin pressure from raw material costs.
  • KWR posted higher Q2 earnings and record adjusted EBITDA as new business wins lifted volumes and revenue, while...

Market outlook

Short term

< 1 year

Neutral

Model confidence3/103 out of 10

Key factors

  • Trading above the 200-day average of 149.41
  • MACD momentum is negative
  • 30-day price change of -5.1%

Medium term

1–3 years

Neutral

Model confidence4/104 out of 10

Key factors

  • Trading above the 200-day average of 149.41
  • Analyst targets imply +23.5% versus the current price
  • MACD momentum is negative

Long term

> 3 years

Positive

Model confidence5/105 out of 10

Key factors

  • Analyst targets imply +23.5% versus the current price
  • Revenue growth of +10.2%
  • P/E ratio of 27.8

Key metrics

Financial health

Revenue Growth10.20%
Profit Margin4.95%
P/E Ratio27.8
ROE7.17%
ROA4.10%
Debt/Equity66.91
P/B Ratio1.9
Op. Cash Flow$131.2M
Free Cash Flow$129.9M

Technical analysis

TrendNeutral
RSI43.1
Support$151.96
Resistance$163.79
MA 20$157.89
MA 50$162.26
MA 200$149.41
MACDBearish
VolumeStable
Fear & Greed Index94.93

Valuation

Fair Value$93.21
Target Price$192.57
Upside/Downside23.48%
GradeFair
TypeBlend
Dividend Yield1.34%

Risk assessment

Beta1.30
Volatility22.14%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.